99mTc-MIP-1404: Ph III ongoing

An IDMC recommended continuation of the open-label, North American Phase III proSPECT-AS trial evaluating a single 20 mCi IV injection of 99mTc-MIP-1404 based on an interim analysis. The trial has enr...